Transpara, the leading Artificial Intelligence support system for breast cancer screening that uses deep learning algorithms to automatically detect potential breast cancer in 2D and 3D mammograms, has achieved...
Covera Health Enhances its Radiology Center of Excellence Program with Mammography AI for Breast Cancer Detection
Covera Health, the country’s leading provider of clinical analytics solutions to reduce medical misdiagnoses and improve healthcare quality, announced the integration of ScreenPoint Medical’s artificial intelligence (AI) tools into its...
Diagnostic Centers of America (DCA), Boca Radiology Group, and ScreenPoint Medical, Inc., Announce Strategic Partnership to Improve Early Detection using Artificial Intelligence in Mammography
Diagnostic Centers of America (DCA) and Boca Radiology Group has partnered with ScreenPoint Medical, Inc., to improve early detection and treatment using Transpara©, an AI solution that uses deep...
Women’s Imaging Associates implements ScreenPoint Medical’s Transpara® to bring cutting edge 2D and 3D breast AI to benefit the women of Alabama
Women’s Imaging Associates and ScreenPoint Medical have announced today a strategic partnership to drive the earlier detection of breast cancer with AI. Read the full release
ScreenPoint Medical launches Transpara® 1.6.0, the first breast AI solution for both 2D and 3D mammography in the USA. U.S. FDA clears Transpara 1.6.0 manufactured by ScreenPoint Medical, the...
Study confirms findings of the Transpara® by ScreenPoint Medical AI mammogram decision support system
ScreenPoint Medical’s Scientists who developed the Transpara AI decision support system which helps radiologists to identify potential breast cancers earlier and faster, say a new international study by Google...